The primary duty of the regulatory bodies across the world is to prevent  harm from unsafe drugs. In the United States, the law ensures that  there shall be a written stability testing programme to assess the  stability characteristics of drug products. Stability is the critical  quality attribute of a drug product. Further it ensures the capacity of a  drug substance, said Kim Huynh-Ba, Technical director of Pharmalytik,  Newark in USA.
She was addressing a gathering attended in the  workshop organized as part of the IPA Convention 2010 on Stability  Testing for global submission, in Chennai on March 12.
[adsense:336x280:8701650588]
Kim said  the purpose of stability testing is to provide evidence on how the  quality of a drug substance or drug product varies with time under the  influence of a variety of environmental factors, such as temperature,  humidity, and light. It permits the establishment of a recommended  storage condition, retest periods and shelf-lives. Another aim of the  stability study is to understand one of the basic properties of the API,  she said.
According to her, if there is a program conducted on  global stability testing, it will help in many ways like improvement in  efficiency and good use of testing. Further it will avoid repeat testing  due to the regional difference. Other important advantage of global  stability testing is that there is facility for all the tests to be  conducted simultaneously at the same lab. Here, the quality can be  ‘measured’ instead of ‘designed’, she said.
According to Prabu  Nambiar, vice president of Vertex Pharmaceuticals, Cambridge, for  compliance of GMP and regulatory requirements, stability testing is  necessary. He said if there is no stability, there is no drug at all.
Later while speaking to Pharmabiz, he said there are different norms  for stability testing compared to geographical and climatical phenomena.  “There are global regulatory challenges. Products for US may not be  stable for Chennai. They depend on the temperature. So the storage  conditions vary from place to place. Some drugs require long term  storage condition. The stability needs of ASEAN countries are far  different from western countries,” he said.
According to him,  stability testing should be conducted as early as practicable. Though it  depends on the nature of the product, preferably the testing can be  done within 20-30 days of the formulation. He said generally the  stability tests are done for commercial purposes.
 
        
    
 
 
 
 
 
 
